Lin Danlin, Liu Jiehong, Ke Chao, Chen Haolin, Li Jing, Xie Yuanyao, Ma Jianhua, Lv Xiaofei, Feng Yanqiu
Department of Medical Imaging, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, China.
School of Biomedical Engineering, Southern Medical University, Guangzhou, China.
Clin Neuroradiol. 2024 Dec;34(4):817-826. doi: 10.1007/s00062-024-01421-3. Epub 2024 Jun 10.
To investigate the feasibility of using radiomics analysis of quantitative maps from synthetic MRI to preoperatively predict diffuse glioma grades, isocitrate dehydrogenase (IDH) subtypes, and 1p/19q codeletion status.
Data from 124 patients with diffuse glioma were used for analysis (n = 87 for training, n = 37 for testing). Quantitative T1, T2, and proton density (PD) maps were obtained using synthetic MRI. Enhancing tumour (ET), non-enhancing tumour and necrosis (NET), and peritumoral edema (PE) regions were segmented followed by manual fine-tuning. Features were extracted using PyRadiomics and then selected using Levene/T, BorutaShap and maximum relevance minimum redundancy algorithms. A support vector machine was adopted for classification. Receiver operating characteristic curve analysis and integrated discrimination improvement analysis were implemented to compare the performance of different radiomics models.
Radiomics models constructed using features from multiple tumour subregions (ET + NET + PE) in the combined maps (T1 + T2 + PD) achieved the highest AUC in all three prediction tasks, among which the AUC for differentiating lower-grade and high-grade diffuse gliomas, predicting IDH mutation status and predicting 1p/19q codeletion status were 0.92, 0.95 and 0.86 respectively. Compared with those constructed on individual T1, T2, and PD maps, the discriminant ability of radiomics models constructed on the combined maps separately increased by 11, 17 and 10% in predicting glioma grades, 35, 52 and 19% in predicting IDH mutation status, and 16, 15 and 14% in predicting 1p/19q codeletion status (p < 0.05).
Radiomics analysis of quantitative maps from synthetic MRI provides a new quantitative imaging tool for the preoperative prediction of grades and molecular subtypes in diffuse gliomas.
探讨利用合成磁共振成像(MRI)定量图谱的放射组学分析在术前预测弥漫性胶质瘤分级、异柠檬酸脱氢酶(IDH)亚型及1p/19q共缺失状态的可行性。
采用124例弥漫性胶质瘤患者的数据进行分析(训练组n = 87例,测试组n = 37例)。利用合成MRI获取定量T1、T2及质子密度(PD)图谱。对强化肿瘤(ET)、非强化肿瘤及坏死(NET)和瘤周水肿(PE)区域进行分割,随后进行手动微调。使用PyRadiomics提取特征,然后采用Levene/T、BorutaShap和最大相关最小冗余算法进行特征选择。采用支持向量机进行分类。实施受试者工作特征曲线分析和综合判别改善分析以比较不同放射组学模型的性能。
在组合图谱(T1 + T2 + PD)中使用多个肿瘤亚区域(ET + NET + PE)的特征构建的放射组学模型在所有三项预测任务中均获得最高的曲线下面积(AUC),其中区分低级别和高级别弥漫性胶质瘤、预测IDH突变状态及预测1p/19q共缺失状态的AUC分别为0.92、0.95和0.86。与基于单个T1、T2和PD图谱构建的模型相比,基于组合图谱构建的放射组学模型在预测胶质瘤分级时的判别能力分别提高了11%、17%和10%,在预测IDH突变状态时分别提高了35%、52%和19%,在预测1p/19q共缺失状态时分别提高了16%、15%和14%(p < 0.05)。
合成MRI定量图谱的放射组学分析为弥漫性胶质瘤分级和分子亚型的术前预测提供了一种新的定量成像工具。